B-16. Semisynthetic and synthetic opiates Flashcards
Semi-synthetic opiates
all are phenanthrenes
- Strong μ agonists:
a. Heroin - diacetylmorphine
b. Oxycodone - Weak-Intermediate μ agonists:
a. Dihydrocodeine - Mixed agonist / antagonists:
a. Nalbuphine
b. Buprenorphine - Antagonists:
a. Naloxone
b. Naltrexone
Synthetic opiates
- Strong μ agonists: all are phenylpiperidines (exc. methadone)
a. Meperidine
b. Fentanyl; Al- / Su- / Remifentanil … (Fentanyl family consists of “Al, Sue and Remy”).
c. Methadone - Weak-Intermediate μ agonists:
a. Dextromethorphan
b. Diphenoxylate
c. Loperamide
d. Tramadol
e. Tapentadol - Mixed agonist / antagonists:
a. Butorphanol
b. Pentazocine
Heroin
a phenanthrene. diacetylmorphine. metabolized to morphine via tissue esterases.
Highly lipophilic → enters brain suddenly in high concentration.
Strong euphoric effect.
long-lasting (2 hour DOA).
no medical use - a drug of abuse
Oxycodone
phenanthrene derivative; similar to morphine, better oral absorption.
Indications:
- cancer-related pain and cough.
- other moderate-severe pain.
Often combined with atg naloxone (oral → high first-pass effect; only works in GI to prevent constipation)
Dihydrocodeine
stronger than codeine, weaker than morphine.
Indications: used as analgesic, antitussive (esp. in pleuritis).
Buprenorphine (MOA, kinetics, indications)
MOA: acts as a partial μ agonist and κ antagonist … (all “bu” drugs are partial μ agonists)
Kinetics: long DOA
sublingual admin to avoid first-pass metab; transdermal patch for chronic tx
Indications:
- Breakthrough pain - sublingual
- Chronic pain - transdermal
- Opiate addiction - as “bridge” therapy; slow receptor dissociation → milder withdrawal symptoms
Nalbuphine (MOA, SE, indications)
MOA: acts as a κ agonist and partial μ agonist … (all “bu” drugs are partial μ agonists)
κ receptor not involved in respiratory depression → respiratory dep. effects max out before lethality
Less euphoria → less dependence
Side Effects:
- Dysphoria - κ agonist effect
- Sedation
- Sweating
Indications:
- Pain - moderate to severe
- Surgery - in combo with other anesthetics + for pre- and post-op pain
- Obstetric - analgesia during labor/delivery
Naltrexone
semisynthetic μ atg; given orally; 10 hr DOA; used for treating opiate addiction.
Naloxone
semisynthetic μ atg; 1-2 hour DOA; parenteral; used for opiate overdose (short DOA → repeat doses).
Methadone
a diphenylheptane.
Good oral availability; accumulates in tissues → slow elimination → easier to discontinue due to weaker withdrawal sx.
Used for tx of opiate addiction
Phenylpiperidines (list)
- Meperidine (Pethidine)
- Fentanyl
- Diphenoxylate
- Loperamide
Meperidine (Pethidine) - trade name Demerol (indications, SE)
similar to morphine but with less urinary retention, uterine relaxation, and sedation
no constipation or antitussive effect; no meiosis → OD harder to detect.
Indications:
- Obstetrics - previously the #1 opioid analgesic for L&D; less now due to toxic metabolite + sfx.
- Diverticulitis - preferred analgesic due to effect of ↓ GI luminal pressure.
Side Effects:
- Antimuscarinic effects - dry mouth, visual disturbances, tachycardia, no meiosis
- With MAOI → serotonin syndrome
- metabolite norpethidine can cause seizures
Fentanyl (kinetics, indications, analogs)
100x analgesic effect of morphine; strongest clinical opioid.
Severe respiratory depression effect!
Kinetics: DOA only 30-60 mins → IV, transdermal patch, sublingual pill.
Indications:
- Neuroleptanalgesia - given IV in combo with antipsychotic (droperidol)
- Surgical analgesia - IV
- Chronic Cancer Pain - transdermal patch
- “Breakthrough” pain - any acute increase in pain in cancer pts; as sublingual pill
Analogs -
Sufentanil + Alfentanil - shorter DOAs; Remifentanil - shortest DOA (1-10 mins)
* Remember Sue, Al and Remy as the members of the Fentanyl family; longest name = shortest DOA
Diphenoxylate
antidiarrheal; low BBB entry; combo w/ atropine (trade name Reasec) for watery diarrhea.
Loperamide
antidiarrheal; not absorbed from GI tract